Publications

LeWitt, PA, RA Hauser, M Lu, AP Nicholas, W Weiner, N Coppard, M Leinonen, and JM Savola. 2012. “Randomized Clinical Trial of Fipamezole for Dyskinesia in Parkinson Disease (FJORD Study). Neurology 2012;79:163-9.”. Neurology.

Charles, D, A Brashear, RA Hauser, Li HI, LM Boo, and MF Brin. 2012. “CD 140 Study Group. Efficacy, Tolerability, and Immunogenicity of Onabotulinumtoxina in a Randomized, Double-Blind, Placebo-Controlled Trial for Cervical Dystonia. Clin Neuropharmacol 2012;35:208-14.”. Clin Neuropharmacol.

Elm, JJ, and The NINDS NET-PD Investigators. 2012. “Design Innovations and Baseline Findings in a Long-Term Parkinson’s Trial: The National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson’s Disease Long-Term Study-1. Mov Disord 2012; 27:1513-1521.”. Mov Disord.

Hauser, RA, KE Lyons, and R Pahwa. 2012. “The UPDRS-8: A Brief Clinical Assessment Scale for Parkinson’s Disease. Int J Neurosci 2012;122:333-7.”. Int J Neurosci.

Rascol, O, J Bronzova, RA Hauser, AE Lang, C Sampaio, A Theeuwes, and SV Van De Witte. 2012. “Pardoprunox As Adjunct Therapy to Levodopa in Patients With Parkinson’s Disease Experiencing Motor Fluctuations: Results of a Double-Blind, Randomized, Placebo-Controlled, Trial. Parkinsonism Relat Disord 2012;18:370-6.”. Parkinsonism Relat Disord.

Hauser, RA. 2012. “IPX066: a Novel Carbidopa-Levodopa Extended-Release Formulation. Expert Rev Neurother. 2012;12:133-40.”. Expert Rev Neurother.

Goldman, SM, F Kamel, GW Ross, SA Jewell, GS Bhudhikanok, D Umbach, C Marras, et al. 2012. “Head Injury, α-Synuclein Rep1, and Parkinson’s Disease. Ann Neurol 2012;71:40-8.”. Ann Neurol.

Hauser, RA, and DG Grosset. 2012. “[123I]FP-CIT (DaTscan) SPECT Brain Imaging in Patients With Suspected Parkinsonian Syndromes. J Neuroimaging 2012;22:225-30.”. J Neuroimaging.

Hauser, RA, AL Ellenbogen, LV Metman, A Hsu, MJ O’Connell, NB Modi, HM Yao, SH Kell, and SK Gupta. 2011. “Crossover Comparison of IPX066 and a Standard Levodopa Formulation in Advanced Parkinson’s Disease.”. Mov Disord.

Poewe, W, O Rascol, P Barone, RA Hauser, Y Mizuno, M Haaksma, L Salin, N Juhel, and AH Shapira. 2011. “Extended-Release Pramipexole in Early Parkinson Disease: A 33-Week Randomized Controlled Trial”. Neurology.